SUGAMIDE-PM-2 NANO FAST Tabs - Glimepiride 2mg + Pioglitazone 15mg + Metformin 500mg (In SR) | Intralife Pharmaceuticals
DIASAGE
Premium

SUGAMIDE-PM-2 NANO FAST Tabs

MRP: 1,092

Packaging: 10X14

Pack Type: tablet

Composition:

Glimepiride 2mg + Pioglitazone 15mg + Metformin 500mg (In SR)

Indication:

Complete Control over Uncontrolled Diabetes, IMICKRO Nano Technology gives Immediate and Patterned Release (IPR) drug profile

Description:

This tablet combines Glimepiride 2 mg, Pioglitazone 15 mg, and Metformin Hydrochloride 500 mg (Sustained Release) to provide a comprehensive treatment for type 2 diabetes mellitus.

  • Glimepiride stimulates pancreatic beta cells to increase insulin secretion, lowering blood glucose.

  • Pioglitazone improves insulin sensitivity in muscle and fat tissues, helping glucose uptake.

  • Metformin SR decreases hepatic glucose production and enhances peripheral glucose utilization with a sustained-release profile to reduce gastrointestinal side effects.

This triple-drug combination targets multiple mechanisms to control fasting and post-meal blood sugar, suitable for patients inadequately controlled by dual therapy.

Tags:

Type 2 Diabetes
Oral Antidiabetics
Triple Combination
Sustained Release
Blood Sugar Control
  • Targets blood sugar control via three complementary mechanisms
  • Controls both fasting and post-meal glucose levels
  • Sustained-release Metformin improves tolerance and convenience
  • Helps reduce diabetes complications by effective glucose management
  • Once-daily dose supports adherence

Usage Information

Dosage

Take one tablet daily with food, preferably breakfast Swallow whole; do not crush or chew Follow physician’s guidance for dose adjustments Monitor blood glucose regularly

Side Effects

Hypoglycemia (low blood sugar) Gastrointestinal upset (nausea, diarrhea, abdominal pain) Weight gain, fluid retention (from Pioglitazone) Dizziness, headache Rarely, lactic acidosis (Metformin) or liver enzyme abnormalities

Contraindications

Type 1 diabetes or diabetic ketoacidosis Severe kidney or liver disease Heart failure (especially NYHA class III/IV) Known allergy to any component Bladder cancer (caution with Pioglitazone) Pregnancy or breastfeeding (unless advised) Excessive alcohol use or conditions predisposing to lactic acidosis

Availability

Glimepiride Pioglitazone Metformin 500mg SR, Triple diabetes combo, Type 2 diabetes treatment, Oral antidiabetic tablet, Sustained release diabetes medicine

Glimepiride 2mg + Pioglitazone 15mg + Metformin 500mg SR for Diabetes | Intralife Pharmaceuticals | Intralife